Gastric Cancer
Copyright ©The Author(s) 2002.
World J Gastroenterol. Dec 15, 2002; 8(6): 994-998
Published online Dec 15, 2002. doi: 10.3748/wjg.v8.i6.994
Figure 3
Figure 3 Effects of recombinant human VEGF165 on prolifera-tion of AGS-1, NCI-N87 and KATOIIIcells. The cells were treated with concentrations of VEGF165 indicated, and their vi-ability was assessed using MTT and expressed as mean per-centage of the untreated controls ± SE (n = 4).